News
-
-
-
REGULATED PRESS RELEASE
Signing of the share purchase agreement for the acquisition of a majority stake in Neoen by Brookfield from Impala and other shareholders and of a tender agreement between Brookfield and Bpifrance
Brookfield signs share purchase agreement with Neoen for majority stake acquisition. Tender agreement with Bpifrance signed. Expected regulatory approvals in Q4 2024. Tender offer in Q1 2025 -
-
REGULATED PRESS RELEASE
Schneider Electric launches an offering of bonds convertible into new shares and/or exchangeable for existing shares (OCEANEs) due 2031 for a nominal amount of €750 million and a concurrent repurchase of its outstanding OCEANEs due 2026
Schneider Electric launches €750 million Bonds offering convertible into new shares and/or exchangeable for existing shares, along with a repurchase of outstanding OCEANEs. Details of the transaction, terms, and conditions provided -
-
REGULATED PRESS RELEASE
Gimv increases its stake in TINC – Gimv and Belfius conclude agreement in principle on the sale of the shares of Belfius Insurance in TINC
Gimv increases stake in TINC as Gimv and Belfius agree on share sale deal. Newly created company with Gimv as majority shareholder to ensure stability of TINC's shareholdership -
-
PRESS RELEASE
HORNBACH Group delivers strong Q1 2024/25 results increasing earnings per share y-o-y by 44% – full-year outlook confirmed unchanged
HORNBACH Group reports 44% y-o-y increase in earnings per share for Q1 2024/25. Full-year outlook remains unchanged. Solid results driven by normalized gross margin and cost discipline -
PRESS RELEASE
Kuros Biosciences Announces Peer-Reviewed Publication of MagnetOs MAXA Level 1 Study Outcomes in Spine, Indicating Superiority Over Autograft
Kuros Biosciences announces the publication of MagnetOs MAXA Level 1 study outcomes in Spine, showing superiority over autograft. Study details effectiveness of MagnetOs in posterolateral fusions
